Term
| 40-50% of bacterial causes of acute otitis media |
|
Definition
| Strep pneumo (not type that causes throat infections, gram +) |
|
|
Term
| 30-35% of bacterial causes of actue otitis media |
|
Definition
| H. Inluenzae (up to 40% are beta lactamase producers) |
|
|
Term
| 10-12% of bacterial causes of acute otitis media |
|
Definition
| Moroxella catarholis (up to 75% are beta lactamase producers) |
|
|
Term
| First line therapy for AOM |
|
Definition
| high dose amox to capture pen-intermediate resistant strains |
|
|
Term
| Second line therapy for AOM |
|
Definition
| more beta lactamase stable agnets (Augmentin ER/ES, Cefdinir, Cefproxil, Cefpodozime, Cefuroxime) |
|
|
Term
| Third line therapy for AOM |
|
Definition
| consider IV/IM ceftriazone x 3d |
|
|
Term
| Should be avoided in AOM treatment |
|
Definition
| macrolides, TMP/SMX, cefaclor, loracarbef, cefixime |
|
|
Term
| Common organisms involved in cystitis and pyelonephritis |
|
Definition
| 80-90% E. Coli, 5-15% Staph saprophyticus, 5% Proteus/Klebiella |
|
|
Term
| Recommended therapy for UTIs |
|
Definition
| Phenazopyridine, IV Gent/Tobra for pylonephritis, or possibly IV/PO quinolones, TMP/SMX, Ampicillin/Amoxicillin, Nitrofurantoin, Tetracycline, mandelamine |
|
|
Term
| Treatment for uncomplicated cystitis: |
|
Definition
| emphasis on short course 1-3 days vs 7-10 days (Bactram) |
|
|
